Sussex Research Laboratories Inc. takes occupancy in new NRC Industry Partnership Facility

Sussex Research Laboratories Inc. (Sussex) announced that it is one of six technology-based companies to take occupancy in the new National Research Council (NRC) of Canada’s Industry Partnership Facility (IPF) located at NRC’s flagship site in Ottawa. The IPF exists to foster and assist companies commercializing NRC technologies or expertise, thereby providing economic gain to Canada, particularly to the National Capital Region. The incubating companies also occupy other offices and laboratories throughout the site. The site is also home to the NRC Steacie Institute for Molecular Sciences (NRC-SIMS), the NRC Institute for Biological Sciences (NRC-IBS), the Canadian Space Agency and some NRC executive offices.

NRC is establishing a network of Industry Partnership Facilities (IPFs) at its research institutes across the country to accelerate innovation, commercialization and to foster the growth of technology clusters all across Canada. By locating at an NRC-IPF, small and medium sized enterprises (SMEs) gain access to world-class research facilities and expertise, national and international networks, as well as business intelligence and knowledge dissemination resources.

Back to blog

About Sussex Research Laboratories Inc.

Sussex Research Laboratories Inc. is a global leader in Carbohydrate Synthesis. We excel at translating complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycobiology in applications that promote human health. Our product portfolio and contract research & development services enable our clients and partners to apply discoveries in glycomics for drug development & discovery, drug delivery & targeting, vaccine development and monoclonal antibody development. Experience glyco-enhancement of your small molecule, protein, oligonucleotide or other macromolecule through Sussex Research Laboratories Inc.. We are the GalNAc, Glycan, Ligand, Glycopeptide and Glycoconjugate Specialists.

  • Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

  • Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

  • Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

1 of 3